Bio-Techne Corp (TECH)

Working capital turnover

Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue US$ in thousands 1,219,640 1,159,060 1,136,700 1,105,600 931,032
Total current assets US$ in thousands 608,300 617,419 621,482 605,556 510,606
Total current liabilities US$ in thousands 175,849 159,379 128,509 176,018 152,284
Working capital turnover 2.82 2.53 2.31 2.57 2.60

June 30, 2025 calculation

Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $1,219,640K ÷ ($608,300K – $175,849K)
= 2.82

The working capital turnover ratio for Bio-Techne Corp demonstrates a pattern of fluctuations over the analyzed period from June 30, 2021, to June 30, 2025. In fiscal year 2021, the ratio was recorded at 2.60, indicating a moderate efficiency in utilizing working capital to generate sales. The ratio experienced a slight decline in 2022, decreasing marginally to 2.57, suggesting a minor reduction in operational efficiency. This downward trend continued into 2023, with the ratio reaching 2.31, reflecting a more significant decrease and potentially implying increased working capital relative to sales or a reduction in sales efficiency.

However, in the subsequent fiscal year, 2024, the ratio rebounded to 2.53, illustrating an improvement in working capital utilization. This upward movement indicates a recovery in the company's operational efficiency concerning its working capital investments. The most recent data for 2025 shows an increase to 2.82, which signifies the highest ratio within the observed period. This suggests an enhanced capacity of Bio-Techne Corp to generate sales from its working capital base, potentially reflecting improved operational management or strategic shifts in working capital management.

Overall, the trend in Bio-Techne Corp’s working capital turnover ratio indicates periods of fluctuation with a general tendency towards improvement in the most recent years, culminating in a ratio that surpasses the initial levels observed in 2021. This pattern may imply efforts to optimize working capital efficiency or changes in sales volume relative to working capital investments.